Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

20042,268 citationsJournal Articlebronze Open Access

Authors

Yun‐Fan Liaw · Memorial Hospital of South Bend

Joseph J.�Y. Sung

Abstract

Continuous treatment with lamivudine delays clinical progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis by significantly reducing the incidence of hepatic decompensation and the risk of hepatocellular carcinoma.

Topics & Keywords

Hepatitis B Virus Studies Liver Disease Diagnosis and Treatment Hepatitis C virus research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 351, Issue 15, pp. 1521-1531

DOI: 10.1056/nejmoa033364

Field-Weighted Citation Impact: 69.04